DE602005025083D1 - - Google Patents

Info

Publication number
DE602005025083D1
DE602005025083D1 DE602005025083T DE602005025083T DE602005025083D1 DE 602005025083 D1 DE602005025083 D1 DE 602005025083D1 DE 602005025083 T DE602005025083 T DE 602005025083T DE 602005025083 T DE602005025083 T DE 602005025083T DE 602005025083 D1 DE602005025083 D1 DE 602005025083D1
Authority
DE
Germany
Prior art keywords
amphiphile
compositions
component
structure forming
lamellar particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005025083T
Other languages
German (de)
English (en)
Inventor
Markus Johnsson
Fredrik Tiberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Camurus AB
Original Assignee
Camurus AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0401515.2A external-priority patent/GB0401515D0/en
Priority claimed from GB0407936A external-priority patent/GB0407936D0/en
Application filed by Camurus AB filed Critical Camurus AB
Publication of DE602005025083D1 publication Critical patent/DE602005025083D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Edible Oils And Fats (AREA)
DE602005025083T 2004-01-23 2005-01-21 Expired - Lifetime DE602005025083D1 (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0401515.2A GB0401515D0 (en) 2004-01-23 2004-01-23 Compositions
GB0407936A GB0407936D0 (en) 2004-04-07 2004-04-07 Compositions
PCT/GB2005/000202 WO2005070394A2 (en) 2004-01-23 2005-01-21 Ternary non-lamellar lipid compositions

Publications (1)

Publication Number Publication Date
DE602005025083D1 true DE602005025083D1 (https=) 2011-01-13

Family

ID=34809883

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005025083T Expired - Lifetime DE602005025083D1 (https=) 2004-01-23 2005-01-21

Country Status (8)

Country Link
US (1) US8182834B2 (https=)
EP (1) EP1713446B1 (https=)
JP (1) JP4966018B2 (https=)
AT (1) ATE489942T1 (https=)
CA (1) CA2554052C (https=)
DE (1) DE602005025083D1 (https=)
PL (1) PL1713446T3 (https=)
WO (1) WO2005070394A2 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006075124A1 (en) * 2005-01-14 2006-07-20 Camurus Ab Somatostatin analogue formulations
GB0401513D0 (en) * 2004-01-23 2004-02-25 Camurus Ab Compositions
PL1848403T3 (pl) * 2005-01-14 2010-09-30 Camurus Ab Preparaty bioadhezyjne o działaniu miejscowym
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
US9757461B2 (en) 2005-01-14 2017-09-12 Camurus Ab GnRH analogue formulations
EP1843746B1 (en) * 2005-01-14 2011-03-16 Camurus Ab Somatostatin analogue formulations
KR101245022B1 (ko) 2005-01-21 2013-03-19 카무러스 에이비 약제학적 지질 조성물
US8097239B2 (en) 2005-06-06 2012-01-17 Camurus Ab Controlled-release formulations
EP1888031B1 (en) * 2005-06-06 2013-01-23 Camurus Ab Glp-1 analogue formulations
US20080274195A1 (en) 2005-07-18 2008-11-06 University Of Massachusetts Lowell Compositions and Methods for Making and Using Nanoemulsions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
SG179457A1 (en) 2006-12-01 2012-04-27 Anterios Inc Peptide nanoparticles and uses therefor
SG177184A1 (en) 2006-12-01 2012-01-30 Anterios Inc Amphiphilic entity nanoparticles
CN101765423B (zh) 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
EP2020221B1 (de) * 2007-06-19 2012-02-29 Neubourg Skin Care GmbH & Co. KG DMS (Derma Membrane Structure) in Schaum-Cremes
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
PT104158B (pt) * 2008-08-18 2011-02-24 Univ Do Minho Aplicação da monooleína como novo lípido adjuvante em lipofecção
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
MX350929B (es) 2011-12-05 2017-09-26 Camurus Ab Formulaciones peptidicas robustas de liberación controlada.
BR112014029425A2 (pt) 2012-05-25 2017-06-27 Camurus Ab pré-formulação, dispositivo de administração pré-cheio, kit, processo para a formação de uma pré-formulação, usos de mistura e de um solvente polar, e, método para o tratamento de um sujeito
MX2019005833A (es) 2016-11-21 2019-10-30 Eirion Therapeutics Inc Administracion transdermica de agentes grandes.
CA3133682A1 (en) 2019-03-15 2020-09-24 Saudi Arabian Oil Company Bulk synthesis of janus nanomaterials
WO2021011755A1 (en) 2019-07-16 2021-01-21 Saudi Arabian Oil Company Multipurpose microfluidics devices for rapid on-site optical chemical analysis
US11422285B2 (en) 2020-06-17 2022-08-23 Saudi Arabian Oil Company Nanofluidic chips as micromodels for carbonate reservoirs
US11827850B2 (en) 2020-07-24 2023-11-28 Saudi Arabian Oil Company Enhanced oil recovery with janus nanoparticles
US11773715B2 (en) 2020-09-03 2023-10-03 Saudi Arabian Oil Company Injecting multiple tracer tag fluids into a wellbore
US11660595B2 (en) 2021-01-04 2023-05-30 Saudi Arabian Oil Company Microfluidic chip with multiple porosity regions for reservoir modeling
US11534759B2 (en) 2021-01-22 2022-12-27 Saudi Arabian Oil Company Microfluidic chip with mixed porosities for reservoir modeling
US12253467B2 (en) 2021-12-13 2025-03-18 Saudi Arabian Oil Company Determining partition coefficients of tracer analytes
US12000278B2 (en) 2021-12-16 2024-06-04 Saudi Arabian Oil Company Determining oil and water production rates in multiple production zones from a single production well
US12352146B2 (en) 2023-09-11 2025-07-08 Saudi Arabian Oil Company Method for well stimulation using nanobubbles

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9206593A (pt) 1991-10-04 1995-11-28 Gs Biochem Ab Partículas especialmente partículas coloidais processo de prepará-las a partir de uma fase cristalina líquida homogênea ou fase L3 composição farmacêutica e uso destas partículas
SE518578C2 (sv) 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
PT942780E (pt) * 1997-09-09 2003-11-28 Lyotropic Therapeutics Inc Particulas revestidas processos de obtencao e uso
US6593294B1 (en) * 1998-04-27 2003-07-15 Opperbas Holding B.V. Pharmaceutical composition comprising Factor VIII and neutral liposomes
US6537575B1 (en) * 1999-07-30 2003-03-25 The University Of Chicago Synthetic biological membrane with self organizing properties
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US7008646B2 (en) 2001-02-20 2006-03-07 Patrick Thomas Spicer Cubic liquid crystalline compositions and methods for their preparation
US6936187B2 (en) 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6656385B2 (en) 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
WO2005014162A1 (en) * 2003-08-04 2005-02-17 Camurus Ab Method for improving the properties of amphiphile particles
GB0322033D0 (en) * 2003-09-19 2003-10-22 Camurus Ab Composition

Also Published As

Publication number Publication date
CA2554052A1 (en) 2005-08-04
WO2005070394A3 (en) 2006-01-26
US8182834B2 (en) 2012-05-22
EP1713446B1 (en) 2010-12-01
ATE489942T1 (de) 2010-12-15
CA2554052C (en) 2013-10-22
EP1713446A2 (en) 2006-10-25
WO2005070394A2 (en) 2005-08-04
JP4966018B2 (ja) 2012-07-04
US20080206317A1 (en) 2008-08-28
PL1713446T3 (pl) 2011-05-31
JP2007518784A (ja) 2007-07-12

Similar Documents

Publication Publication Date Title
DE602005025083D1 (https=)
WO2007027941A3 (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
SG161261A1 (en) Lactam compounds and their use as pharmaceuticals
WO2006002361A3 (en) 2-methylpropanamides and their use as pharmaceuticals
UA84318C2 (ru) Гетерополициклические соединения и их применение как метаботропических антагонистов рецепторов глутамата, фармацевтическая композиция на их основе
WO2006013369A3 (en) Compositions forming non-lamellar dispersions
WO2007051810A3 (en) Pharmaceutical use of substituted amides
MX340538B (es) Compuestos amido y sus usos como farmaceuticos.
MX2009009623A (es) Inidol y bencimidazol amidas como inhibidores de la dehidrogenasa hidroxi-esteroide.
SG163518A1 (en) Amido compounds and their use as pharmaceuticals
WO2007090822A3 (de) Pharmazeutische formulierung für aerosole mit zwei oder mehr wirkstoffen und mindestens einer oberflächenaktiven substanz
WO2006012226A3 (en) N-substituted piperidines and their use as pharmaceuticals
TW200626156A (en) Amido compounds and their use as pharmaceuticals
WO2006012227A3 (en) Amido compounds and their use as pharmaceuticals
WO2007085833A3 (en) Pyrimidine derivatives
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
MEP36508A (en) Triazolopyrazine derivatives useful as anti-cancer agents
MXPA05010137A (es) Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina.
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
WO2007022023A3 (en) Film forming spreading agents
ATE500207T1 (de) Fettsäureanhydride enthaltende dispersionspulver
DE602005025082D1 (de) Nicht-lamellare zubereitungen von dioleoyl-phosphatidyl ethanolamin und polysorbat80
WO2006041538A3 (en) A mixture for transdermal delivery of low and high molecular weight compounds
CA2388325A1 (en) Ciclesonide-containing aqueous pharmaceutical composition